Daily non-political popular news in brief.
Growth-factor antibody may treat chronic lung disease affecting premature infants
04-02-2007 · EurekAlert!Researchers from Massachusetts General Hospital, in collaboration with scientists from the Genzyme Corporation, have identified a potential treatment for a chronic lung disease affecting premature infants. The scientists find that the activity of transforming growth factor-beta is elevated in the lungs of an animal model of bronchopulmonary dysplasia and that treatment with an antibody to TGF-beta decreased the growth factor’s activity and improved lung development.
Read more »
Keywords: growth-factor, antibody, treat, chronic, lung, disease, affecting, premature, infants, growth, factor, infant
« Previous | Next »
Similar news on "Growth-factor antibody may treat chronic lung disease affecting premature infants":
- Gene-chip studies provide new leads in treating lung disease of premature newborns
10-03-2007 · EurekAlert!
Some 20 to 40 percent of extremely premature infants suffer abnormal lung development leading to bronchopulmonary dysplasia, a chronic lung disease that can cause long-term breathing problems. Little is known about how to predict whether a premature infant will develop BPD in the weeks after birth, much less how to prevent or treat it. Now, gene-chip studies of these tiny babies’ umbilical cords provide unexpected, much-needed leads into predicting and treating this debilitating condition.
Similar news · Read more »
- New system for classifying infant lung disease developed
11-30-2007 · EurekAlert!
A new classification system of rare lung diseases in infants is improving diagnosis and treatment. The system clears up considerable confusion about how to classify and treat diseases that are rarely seen by most doctors and pathologists, says Gail H. Deutsch, MD, lead author of the multi-center study that developed the new guidelines.
Similar news · Read more »
- New therapeutic targets in the treatment of ulcerative colitis
11-13-2007 · EurekAlert!
The morbidity of ulcerative colitis, a chronic inflammatory disease of the colon with unclear etiology and pathogenesis, is a common disease in Europe and has been increasing in China. A research team in China has found that ulcerative colitis is closely related to the over expression of matrix metolloproteinas-1 (MMP-1) and tumor necrosis factor-alpha (TNF-alpha). This finding may bring about new ways to deal with this difficult-to-treat disease.
Similar news · Read more »
- Lung cancer-derived EGFR mutants exhibit intrinsic differences in inhibitor sensitivity
03-12-2007 · EurekAlert!
A new study sheds light on how some small-molecule tyrosine kinase inhibitors, including two that are currently being used clinically to treat cancer, interact with wild-type and mutated forms of the epidermal growth factor receptor (EGFR).
Similar news · Read more »
- Lungs try to repair damaged elastic fibers
11-03-2006 · EurekAlert!
The lungs of patients suffering chronic obstructive pulmonary disease (COPD) attempt to repair damaged elastic fibers, a new finding that contradicts the conventional wisdom on the capabilities of the adult lung. The researchers found that synthesis of elastin, a gene linked to elastic fiber growth, is increased in the moderately diseased tissue of COPD patients. Elastic fibers allow the lung to expand and contract with breathing.
Similar news · Read more »
- 'Wurst' ensures that the respiratory system works
06-13-2007 · EurekAlert!
A newly discovered transmembrane protein called "Wurst" appears to play a decisive role in breathing -- possibly in all animals, from flies to human beings. The protein could offer an exciting starting point for the development of new drugs to treat respiratory problems such as impaired lung function in premature infants.
Similar news · Read more »
- Genetics a key factor in premature infants' devastating eye disease
11-22-2006 · EurekAlert!
Genetics play a major role in predisposing infants to retinopathy of prematurity (ROP), a disease prevalent in premature infants that disrupts normal blood vessel development of the retina and can lead to blindness, researchers at Yale School of Medicine report in the November issue of Pediatrics.
Similar news · Read more »
- T-beta-RIII joins the fight against breast cancer
12-07-2006 · EurekAlert!
Although the soluble factor TGF-beta suppresses tumor cell growth in early breast cancer, high TGF-beta levels later in disease are associated with a poor outcome. A new study using human breast cancer samples and mice, indicates that changes in expression of one TGF-beta receptor component, T-beta-RIII, might explain the distinct effects of TGF-beta at the different stages of breast cancer and that analysis of T-beta-RIII levels might help clinicians decide how aggressively to treat patients.
Similar news · Read more »
- Eltrombopag studied in Idiopathic Thrombocytopenic Purpura
11-28-2007 · EurekAlert!
There are estimated to be between 50,000-100,000 individuals in the US diagnosed with chronic Immune Thrombocytopenic Purpura, an autoimmune disease that dramatically reduces the number of platelets in their blood -- causing bruises, nosebleeds and, sometimes, life-threatening brain hemorrhages. Now, the results of an international multicenter clinical research study led by NewYork-Presbyterian Hospital/Weill Cornell Medical Center demonstrate that an investigational oral platelet growth factor called eltrombopag successfully increased platelet counts and decreased bleeding in patients with the condition.
Similar news · Read more »
- Cigarettes leave deadly path by purging protective genes
01-23-2008 · EurekAlert!
A University of Rochester scientist discovered that the toxins in cigarette smoke wipe out a gene that plays a vital role in protecting the body from the effects of premature aging. Without this gene we not only lose a bit of youthfulness -- but the lungs are left open to destructive inflammation and diseases such as chronic obstructive pulmonary disease and lung cancer.
Similar news · Read more »
